Premature Menopause Linked to Increased Lifetime Risk for Coronary Heart Disease
via HealthDayTHURSDAY, March 19, 2026 -- Premature menopause is associated with increased lifetime risk for coronary heart disease (CHD) in Black and White women, according to a study published online March 18 in JAMA Cardiology.
Priya M. Freaney, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues calculated lifetime risk estimates of incident CHD and estimated years lived free of and with CHD by premature menopause status stratified by self-identified race in a prospective population-based cohort study with 163,600 person-years of follow-up from 1964 to 2018. Individual-level data were included from postmenopausal women (aged 55 to 69 years) who self-identified as Black or White across six U.S. cohorts (3,522 Black women and 6,514 White women).
The researchers found that premature natural menopause occurred more often in Black than White women (15.5 versus 4.8 percent). Premature menopause was associated with an increased lifetime risk for incident CHD, with hazard ratios of 1.41 and 1.39 for Black and White women, respectively. The mean years lived free of CHD were 18.2 and 19.1 for Black women with and without premature menopause, respectively; a similar pattern was seen for White women, but neither met statistical significance.
"The vast majority of heart disease is preventable, but people need to know that they're at risk early in life because effective prevention takes decades," Freaney said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-20 01:53
Read more
- AI Therapist? It Falls Short, a New Study Warns
- Ultra-Processed Foods Linked To Heart Attack, Stroke, Cardiac Arrest
- FDA Provides Fast Track Designation to Nipocalimab for Systemic Lupus Erythematosus
- Telemedicine for Mental Health Services Failing to Significantly Expand Rural Access
- Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions